Search - tctmd.com

Displaying 61 - 80 of 1511

Sort: Relevancy | Date

Presentation TCT 2024

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

Presenter: Kazuki Aihara

October 29, 2024

Presentation TCT 2024

TCT 1364: A Case of Very Late Stent Thrombosis 7 Years After Drug-Eluting Stent Implantation

Presenter: Masaya Kusuda

October 29, 2024

Presentation TCT 2024

TCT 15: Impact of High Lipoprotein(a) Levels on 5-Year Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent in Korean Population

Presenter: Woo Jin Ahn

October 29, 2024

Presentation TCT 2024

TCT 569: Outcomes of Patients With Left Main Lesions Treated With Hybrid Drug-eluting Stent and Drug-coated Balloon Strategy

Presenter: Nancy Virginia

October 29, 2024

Presentation TCT 2024

TCT 39: Comparison of Clinical Outcomes Among Balloon Angioplasty, Drug-Coated Balloon, and the Second or Newer Drug-Eluting Stent

Presenter: Yuko Kiyohara

October 28, 2024

Presentation TCT 2024

TCT 433: Five-Year Clinical Results of Patients Treated With Angiolite® Drug Eluting Stents: Real Life Registry (Epic02 - Rango Study)

Presenter: Armando Perez de Prado

October 28, 2024

Presentation TCT 2024

TCT 441: Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: A Systematic Review and Meta-Analysis

Presenter: Denise Pellegrini

October 28, 2024

Presentation TCT 2024

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART

Presenter: David Erlinge

October 28, 2024

Presentation TCT 2024

TCT 1011: Drug-Eluting Stent or Bioresorbable Vascular Scaffold for Preventive PCI: Post-Hoc Analysis From the PREVENT Trial

Presenter: Han Su Park

October 28, 2024

Presentation TCT 2024

TCT 392: Impact of Drug-Eluting Stent Eccentricity on Clinical Outcomes After Rotational Atherectomy for Calcified Coronary Artery

Presenter: Hisanori Yui

October 28, 2024

Presentation TCT 2024

TCT 416: Impact of Total Stent Length on Long-Term Clinical Outcomes With Newer-Generation Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: A Subgroup Analysis From the Biostemi ES Randomized Trial

Presenter: Juan F. Iglesias

October 28, 2024

Presentation TCT 2024

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

Presenter: Hesham Refaat

October 28, 2024

Presentation TCT 2024

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary DES From the INFINITY-SWEDEHEART Randomized Clinical Trial

Presenter: David Erlinge

October 28, 2024

Presentation TCT 2024

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

Presenter: Jeremy Levett

October 28, 2024

Presentation TCT 2024

TCT 358: Case Series of Coronary Artery Pseudoaneurysm With Extra Luminal Migration of Drug Eluting Stent Following Percutaneous Coronary Intervention

Presenter: Arun Mohanty

October 27, 2024

Presentation TCT 2024

TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind”

Presenter: Emi Kearon

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News ESC 2024

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

Todd Neale

September 09, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

Advertisement

TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS

TCT 1364: A Case of Very Late Stent Thrombosis 7 Years After Drug-Eluting Stent Implantation

TCT 15: Impact of High Lipoprotein(a) Levels on 5-Year Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent in Korean Population

TCT 569: Outcomes of Patients With Left Main Lesions Treated With Hybrid Drug-eluting Stent and Drug-coated Balloon Strategy

TCT 39: Comparison of Clinical Outcomes Among Balloon Angioplasty, Drug-Coated Balloon, and the Second or Newer Drug-Eluting Stent

TCT 433: Five-Year Clinical Results of Patients Treated With Angiolite® Drug Eluting Stents: Real Life Registry (Epic02 - Rango Study)

TCT 441: Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: A Systematic Review and Meta-Analysis

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART

TCT 1011: Drug-Eluting Stent or Bioresorbable Vascular Scaffold for Preventive PCI: Post-Hoc Analysis From the PREVENT Trial

TCT 392: Impact of Drug-Eluting Stent Eccentricity on Clinical Outcomes After Rotational Atherectomy for Calcified Coronary Artery

TCT 416: Impact of Total Stent Length on Long-Term Clinical Outcomes With Newer-Generation Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: A Subgroup Analysis From the Biostemi ES Randomized Trial

TCT 449: Long Term Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease

1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary DES From the INFINITY-SWEDEHEART Randomized Clinical Trial

TCT 445: Three-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small Coronary Arteries: A Systematic Review and Meta-Analysis

TCT 358: Case Series of Coronary Artery Pseudoaneurysm With Extra Luminal Migration of Drug Eluting Stent Following Percutaneous Coronary Intervention

TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind”

What’s Going to Be Big at TCT 2024?

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content